Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

167.77
+0.11000.07%
Post-market: 167.70-0.0700-0.04%19:59 EDT
Volume:7.16M
Turnover:1.20B
Market Cap:43.56B
PE:-11.80
High:168.80
Open:167.75
Low:167.41
Close:167.66
52wk High:176.60
52wk Low:133.73
Shares:259.67M
Float Shares:259.67M
Volume Ratio:0.91
T/O Rate:2.76%
Dividend:2.53
Dividend Rate:1.51%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.27
PE(LYR):-11.80

Loading ...

BofA Adjusts Price Target on HCA Healthcare to $450 From $425

MT Newswires Live
·
Sep 14

BofA Adjusts Price Target on AMN Healthcare Services to $28 From $26

MT Newswires Live
·
Sep 14

BofA Adjusts Price Target on Acadia Healthcare to $17 From $14.50

MT Newswires Live
·
Sep 14

Potential Buyer Emerges for Johnson & Johnson's Orthopedics Unit

Deep News
·
Sep 14

Perspective Therapeutics Enters Cancer Clinical Trial Collaboration With Merck; Shares Up Pre-Bell

MT Newswires Live
·
Sep 14

Healthcare Costs Are Rising Twice as Fast as Everything Else: Inside Milliman’s Healthcare Inflation ETFs (MHIG, MHIP)

TIPRANKS
·
Sep 14

Max Healthcare to Engage Investors at J.P. Morgan India Conference 2026

TIPRANKS
·
Sep 14

Perspective Therapeutics Partners with Merck to Test [212Pb]PSV359 with Keytruda in FAP-Α-Positive Solid Tumors

Reuters
·
Sep 14

Perspective Therapeutics, - Co Sponsors Study; Merck Provides Pembrolizumab at no Cost

THOMSON REUTERS
·
Sep 14

Doximity’s Underappreciated AI Ecosystem and Health-System Traction Support Unchanged $35 Buy Target

TIPRANKS
·
Sep 14

Buy Rating Reiterated on Tenet Healthcare as Durable Cost Cuts, ASC Strength and AI Efficiencies Support Unchanged $274 Price Target

TIPRANKS
·
Sep 14

Johnson & Johnson reports PAPILLON study meets primary endpoint

TIPRANKS
·
Sep 14

Market Chatter: Apollo Global in Talks to Buy J&J Orthopedics Unit for $20 Billion

MT Newswires Live
·
Sep 14

One State's Battle to Stop People from Taking Unapproved Weight-Loss Drugs

Dow Jones
·
Sep 14

Nanobiotix announces updated safety, efficacy data from JNJ-1900 study

TIPRANKS
·
Sep 14

UMP Healthcare Sets Board Meeting to Approve 2026 Annual Results and Consider Dividend

TIPRANKS
·
Sep 14

Johnson & Johnson Says Lung Cancer Drug Combination Extends Median Survival to Over 34 Months

MT Newswires Live
·
Sep 14

Health Care Roundup: Market Talk

Dow Jones
·
Sep 14

J&J Shares up 1.2% Premarket After Report Co's Orthopedics Unit Draws Apollo Interest in Potential $20 Bln Deal

THOMSON REUTERS
·
Sep 14

Brown Advisory US Smaller Companies Trust Reveals August Portfolio Tilt Toward Industrials, Healthcare and Tech

TIPRANKS
·
Sep 14